Cesar A. Soutullo, MD, PhD

Biography

Cesar A. Soutullo, MD, PhD, is John S. Dunn Professor at McGovern Medical School, Vice Chair and Chief of Child & Adolescent Psychiatry, and Director of the ADHD Outpatient Program at the UTHealth – Houston Louis Faillace MD Department of Psychiatry and Behavioral Sciences. He is Board Certified by the American Board of Psychiatry and Neurology in general adult and child and adolescent psychiatry. He studies the early stages, phenomenology and psychopharmacology of ADHD and pediatric Mood Disorders (depression and bipolar). His main research now is in the Texas Youth Depression and suicide research network, part of the Texas Child Mental Health Care Consortium, the Greater Houston Area Pediatric Bipolar Registry, and the ADHD Treatment  Optimization project at UT Physicians Clinics.

He completed his MD at the Complutense University of Madrid (Spain), he then trained in Internships in emergency and internal medicine, general and orthopedic surgery in the United Kingdom. He completed his Residency in Psychiatry, a Fellowship in Biological Psychiatry at the University of Cincinnati Hospital, Cincinnati, Ohio, USA, and a Fellowship in Child and Adolescent Psychiatry at Cincinnati Children’s Hospital. He received numerous awards such as: AACAP Presidential Scholar Award, AAP Fellowship in Academic Psychiatry, Emory University Young Faculty Development Program, Society of Biological Psychiatry Fellowship Award, APA Research Colloquium for Junior Investigators, Stanley Foundation/NAMI Research Award. Recently he was awarded the Dean’s Teaching Excellence Award at McGovern Medical School in 2020, 2021 and 2025, and the AACAP Distinguished Fellow Award in 2024.

He was appointed Founding Director of the Child and Adolescent Psychiatry Unit at the University of Navarra for two decades, where he completed his PhD in Neurosciences. He received the Extraordinary Thesis Award for his dissertation on Phenomenology in children at high risk of developing bipolar disorder. In 2004 he founded and directed the only (till 2023) Child and Adolescent Psychiatry Fellowship in Spain. He developed a Clinical Trials Program for the approval of several ADHD medications by the European Medicines Agency (European Union “FDA”).

He is a member of the EUNETHYDIS Guidelines Group (European Network of Hyperkinetic/ADHD Disorder), the WPA ADHD section (Secretary: 2017-2019), the World Federation on ADHD Scientific Program Committee, and the AACAP Clinical Essentials Committee. He was expert reviewer of the Spanish ADHD and Pediatric Depression Clinical Guidelines, Member of the ADHD Care Optimization Mental Health Strategy (Spanish Ministry of Health). He Coordinated the multidisciplinary Spanish Plan of Action in ADHD (PANDAH). He was Treasurer on the Spanish Association of Child and Adolescent Psychiatry’s Board.

Dr. Soutullo extensive publications (h index: 35) include over 116 original papers, 140 books, review papers or book chapters, and 323 posters in national & international conferences. He serves as a reviewer in 70 Journals and in the Editorial Committee of 19 Journals. He is listed top 0.2% author (Percentile 99.8) on ADHD Worldwide.

https://expertscape.com/au/attention+deficit+disorder+with+hyperactivity/Soutullo%2C+C

Dr. Soutullo has mentored hundreds of trainees from graduate students to PhDs and Post-docs, from Medicine, Psychiatry, Pediatrics, Psychology, Nursing and Social Work. He has directed 9 PhD dissertations, and has lectured close to 600 talks in conferences and meetings worldwide.